TELA Bio 

$0.8000
15
-$0.06-6.98% Today

Statistics

Day High
0.9
Day Low
0.774
52W High
2.2
52W Low
0.501
Volume
168,400
Avg. Volume
193,546
Mkt Cap
32.27M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.42
-0.34
-0.26
-0.17
Expected EPS
-0.17368
Actual EPS
N/A

Financials

-54.6%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
138.6MRevenue
-75.68MNet Income

Analyst Ratings

2.00Average Price Target
The highest estimate is 3.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TELA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson operates in the medical devices segment, offering products that could compete with TELA Bio's soft tissue reinforcement solutions.
Medtronic
MDT
Mkt Cap102.97B
Medtronic offers a wide range of medical devices that can compete with TELA Bio's offerings, especially in the surgical and wound care markets.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation provides medical solutions that could directly compete with TELA Bio's hernia repair and reconstructive surgery products.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation's medical and surgical equipment, including surgical meshes, can compete with TELA Bio's portfolio.
Baxter International
BAX
Mkt Cap10.77B
Baxter International Inc. offers advanced surgical products, including biologics and biosurgery products, that compete with TELA Bio's solutions.
Abbott Laboratories
ABT
Mkt Cap153.59B
Abbott Laboratories, with its range of medical devices and health care products, competes in the same space as TELA Bio, particularly in surgical care.
Intuitive Surgical
ISRG
Mkt Cap145.58B
Intuitive Surgical, known for its robotic-assisted surgical systems, competes indirectly by offering advanced surgical options that could reduce the need for traditional surgical meshes.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, offering products that can be used in procedures similar to those targeted by TELA Bio.
Integra Lifesciences
IART
Mkt Cap1.32B
Integra LifeSciences, a provider of regenerative technologies, directly competes with TELA Bio in the market for surgical reconstruction and repair products.

About

Operating as a commercial-stage medical technology firm, TELA Bio, Inc. is dedicated to improving patient outcomes through advanced soft-tissue reconstruction solutions. Their approach emphasizes the preservation and restoration of the body's natural anatomy. The company offers a diverse portfolio of specialized products, including their flagship OviTex Reinforced Tissue Matrix, extensively utilized for hernia repair and abdominal wall reconstruction. Additionally, OviTex PRS Reinforced Tissue Matrix products cater to specific requirements within plastic and reconstructive surgery, addressing current gaps in treatment. They also provide a specialized OviTex variant designed for laparoscopic and robotic procedures. This sterile, reinforced tissue matrix is derived from ovine rumen and strengthened with polypropylene fiber, specifically engineered for use in minimally invasive hernia repairs. TELA Bio distributes its offerings primarily within the United States, utilizing a dedicated direct sales team. Established in 2012, TELA Bio, Inc. is headquartered in Malvern, Pennsylvania.
Show more...
CEO
Mr. Antony Koblish
Employees
209
Country
United States
ISIN
US8723811084

Listings

0 Comments

Share your thoughts

FAQ

What is TELA Bio stock price today?
The current price of TELA is $0.80 USD — it has decreased by -6.98% in the past 24 hours. Watch TELA Bio stock price performance more closely on the chart.
What is TELA Bio stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange TELA Bio stocks are traded under the ticker TELA.
Is TELA Bio stock price growing?
TELA stock has fallen by -5.88% compared to the previous week, the month change is a -11.6% fall, over the last year TELA Bio has showed a -52.94% decrease.
What is TELA Bio market cap?
Today TELA Bio has the market capitalization of 32.27M
When is the next TELA Bio earnings date?
TELA Bio is going to release the next earnings report on August 12, 2026.
What were TELA Bio earnings last quarter?
TELA earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.18 USD resulting in a -14.17% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is TELA Bio revenue for the last year?
TELA Bio revenue for the last year amounts to 138.6M USD.
What is TELA Bio net income for the last year?
TELA net income for the last year is -75.68M USD.
How many employees does TELA Bio have?
As of June 15, 2026, the company has 209 employees.
In which sector is TELA Bio located?
TELA Bio operates in the Health & Wellness sector.
When did TELA Bio complete a stock split?
The last stock split for TELA Bio was on October 15, 2007 with a ratio of 1:250.
Where is TELA Bio headquartered?
TELA Bio is headquartered in Malvern, United States.